ICCO Stock Overview
InterCare DX, Inc. operates as a biomedical and other software products development and services company.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
InterCare DX, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.088 |
| 52 Week High | US$0.088 |
| 52 Week Low | US$0.017 |
| Beta | 0.075 |
| 1 Month Change | 194.67% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | 194.67% |
| 5 Year Change | 1,668.00% |
| Change since IPO | 194.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| ICCO | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | -1.3% | -3.5% |
| 1Y | n/a | -2.9% | 20.2% |
Return vs Industry: Insufficient data to determine how ICCO performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how ICCO performed against the US Market.
Price Volatility
| ICCO volatility | |
|---|---|
| ICCO Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: ICCO's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine ICCO's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | n/a | Anthony Dike | www.intercare.com |
InterCare DX, Inc. operates as a biomedical and other software products development and services company. It creates, publishes, and markets software products that are embedded with sound, text, and video for relaxation training and stress management. The company also develops an integrated Internet-ready and RFID enabled applications, which target education, hospitality, legal system, human capital, and healthcare industry markets.
InterCare DX, Inc. Fundamentals Summary
| ICCO fundamental statistics | |
|---|---|
| Market cap | US$6.57m |
| Earnings (TTM) | -US$811.26k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-8.1x
P/E RatioIs ICCO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ICCO income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$314.65k |
| Gross Profit | -US$314.65k |
| Other Expenses | US$496.61k |
| Earnings | -US$811.26k |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.011 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -99.6% |
How did ICCO perform over the long term?
See historical performance and comparison